SEC Form 4 · accession 0001209191-17-037357
IRONWOOD PHARMACEUTICALS INC · IRWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas E Williams
Director
Period of report
May 31, 2017
Accepted (ET)
Jun 2, 2017 · 5:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001446847
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | May 31, 2017 | A | 15,625 | $0.00 | A | 75,633 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Issued pursuant to the Director Compensation Plan, effective as of January 2014.
Remarks
Exhibit 24: Power of Attorney